Table 4.
Prescription opioid exposures as risk factors for opioid overdose and adjusted odds ratios (exposed vs non-exposed)
| Year | Adjusted odds ratios [95% CI] | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Overall | |
| Agonist | ||||||||||
| Morphine |
1.58**** [1.41–1.76] |
1.31**** [1.15–1.48] |
1.36**** [1.26–1.47] |
1.36**** [1.28–1.45] |
1.33**** [1.25–1.42] |
1.49**** [1.42–1.56] |
1.56**** [1.49–1.63] |
1.53**** [1.46–1.60] |
1.59**** [1.51–1.67] |
1.44**** [1.42–1.47] |
| Fentanyl |
1.05 [0.94–1.17] |
1.22** [1.07–1.38] |
1.23**** [1.14–1.33] |
1.24**** [1.16–1.32] |
1.56**** [1.45–1.68] |
1.27**** [1.22–1.33] |
1.33**** [1.27–1.39] |
1.47**** [1.40–1.54] |
1.51**** [1.42–1.60] |
1.22**** [1.20–1.25] |
| Oxycodone |
1.72**** [1.54–1.92] |
1.68**** [1.49–1.90] |
1.74**** [1.60–1.88] |
1.60**** [1.50–1.71] |
1.78**** [1.66–1.91] |
1.73**** [1.65–1.82] |
1.82**** [1.74–1.91] |
1.89**** [1.80–1.98] |
1.90**** [1.80–2.01] |
1.70**** [1.67–1.73] |
| Hydromorphone |
1.97**** [1.74–2.23] |
1.66**** [1.45–1.91] |
1.88**** [1.73–2.04] |
1.64**** [1.54–1.75] |
1.71**** [1.59–1.83] |
1.76**** [1.68–1.84] |
1.79**** [1.71–1.87] |
1.95**** [1.86–2.04] |
1.89**** [1.80–1.99] |
1.81**** [1.77–1.84] |
| Hydrocodone |
1.24** [1.08–1.42] |
1.01a [0.85–1.20] |
1.19*** [1.08–1.30] |
1.31**** [1.22–1.41] |
1.17**** [1.08–1.27] |
1.26**** [1.20–1.33] |
1.23**** [1.17–1.30] |
1.25**** [1.18–1.33] |
1.18**** [1.10–1.27] |
1.12**** [1.09–1.15] |
| Meperidine |
1.23 [0.94–1.61] |
0.98a [0.64–1.50] |
1.09 [0.96–1.24] |
1.13* [1.02–1.30] |
1.15* [1.02–1.30] |
1.07 [0.99–1.15] |
1.08* [1.00–1.16] |
1.14** [1.05–1.23] |
1.01a [0.93–1.11] |
1.09**** [1.06–1.13] |
| Tramadol |
3.70**** [3.10–4.41] |
3.47**** [2.86–4.20] |
3.01**** [2.68–3.38] |
2.69**** [2.45–2.95] |
2.11**** [1.91–2.34] |
2.21**** [2.08–2.36] |
2.16**** [2.03–2.30] |
1.88**** [1.76–2.01] |
1.50**** [1.36–1.65] |
2.20**** [2.14–2.27] |
| Codeine |
0.96 [0.75–1.22] |
0.81 [0.58–1.13] |
0.96 [0.79–1.15] |
0.95 [0.81–1.12] |
0.71*** [0.58–0.85] |
0.89 [0.78–1.01] |
0.89* [0.78–1.00] |
0.69**** [0.60–0.80] |
0.73** [0.60–0.89] |
0.78**** [0.74–0.83] |
| Loperamide |
2.08**** [1.57–2.75] |
1.41 [0.95–2.10] |
2.20**** [1.85–2.61] |
2.16**** [1.87–2.49] |
2.11**** [1.80–2.47] |
2.12**** [1.92–2.35] |
2.17**** [1.98–2.39] |
1.96**** [1.77–2.17] |
1.63**** [1.44–1.85] |
2.03**** [1.94–2.12] |
| Diphenoxylate |
1.63* [1.01–2.64] |
1.69 [0.98–2.93] |
2.06**** [1.56–2.72] |
1.88**** [1.45–2.43] |
1.57** [1.16–2.12] |
1.33** [1.10–1.62] |
1.39*** [1.16–1.67] |
1.69**** [1.37–2.09] |
1.79**** [1.38–2.32] |
1.48**** [1.36–1.61] |
| Methadone |
7.86**** [6.34–9.74] |
6.36**** [4.88–8.28] |
7.12**** [6.10–8.32] |
7.07**** [6.23–8.03] |
6.59**** [5.66–7.67] |
6.78**** [6.14–7.49] |
6.47**** [5.86–7.1] |
6.53**** [5.85–7.30] |
5.46**** [4.78–6.22] |
6.51**** [6.23–6.80] |
| Partial agonist | ||||||||||
| Nalbuphine |
0.38**** [0.26–0.57] |
0.38**** [0.25–0.60] |
0.46**** [0.34–0.61] |
0.54**** [0.43–0.66] |
0.63**** [0.50–0.79] |
0.46**** [0.39–0.54] |
0.57**** [0.50–0.66] |
0.52**** [0.45–0.60] |
0.91**** [0.78–1.07] |
0.56**** [0.53–0.60] |
| Butorphanol |
0.19**** [0.09–0.44] |
0.08*** [0.02–0.34] |
0.10**** [0.05–0.19] |
0.13**** [0.06–0.29] |
0.06**** [0.03–0.14] |
0.11**** [0.08–0.17] |
0.05**** [0.03–0.08] |
0.11**** [0.06–0.18] |
0.08**** [0.04–0.16] |
0.09**** [0.07–0.11] |
| Buprenorphine |
3.14**** [1.80–5.46] |
1.90 [0.78–4.61] |
2.33**** [1.58–3.44] |
3.37**** [2.48–4.60] |
5.14**** [3.73–7.10] |
3.35**** [2.73–4.11] |
2.77**** [2.19–3.49] |
2.56**** [2.05–3.21] |
1.74**** [1.29–2.35] |
2.89**** [2.63–3.19] |
| Antagonist | ||||||||||
| Naloxone |
6.40**** [5.70–7.19] |
5.70**** [5.00–6.51] |
4.19**** [3.85–4.55] |
3.93**** [3.68–4.20] |
2.80**** [2.61–3.01] |
3.50**** [3.34–3.67] |
3.13**** [3.00–3.28] |
2.49**** [2.38–2.61] |
2.53**** [2.3–2.67] |
3.24**** [3.18–3.31] |
CI confidence interval
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
aPower less than 80%